Estela Rodriguez: AI to Predict Immunotherapy Response in Advanced NSCLC
Estela Rodriguez, Associate Director of Community Outreach-Thoracic Oncology and Co-Lead Thoracic Site Disease Group, Associate Director of Community Outreach at Sylvester Comprehensive Cancer Center, shared a post on X:
“Looking forward to seeing more of this work: Deep Learning AI Model for Predicting Immunotherapy Response in Advanced NSCLC using available pathology histology slides (in addition to PDL1 expression).”
Title: Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer
Authors: Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao Alessi, Alessio Cortellini, Fabrizio Citarella, Lorenzo Nibid, Giuseppe Perrone, Elio Adib, Claudia Fulgenzi, Cassio Hidalgo Filho, Alessandro Di Federico, Falah Jabar, Sayed Hashemi, Ilias Houda, Elin Richardsen, Lill-Tove Rasmussen Busund, Tom Donnem, Idris Bahce, David Pinato, Åslaug Helland, Lynette Sholl, Mark Awad, David Kwiatkowski
Read the Full Article on JAMA Network.
More posts featuring Estela Rodriguez on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023